Ikena Oncology, Inc. , a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs.
Ikena Oncology stock last closed at $1.35, down 1.46% from the previous day, and has decreased 23.73% in one year. It has overperformed other stocks in the Biotechnology industry by 0.53 percentage points. Ikena Oncology stock is currently +39.03% from its 52-week low of $0.97, and -30.41% from its 52-week high of $1.94.
As of Jun 13, 2025, there are 48.26M shares of IKNA outstanding. The market value of IKNA is $65.15M. In the last 24 hours, 71,000 IKNA shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy IKNA shares.
Based on our research, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, you'll need to fill out some personal information so you are able to buy IKNA today.
Now that you have filled out your info on one of the best stock apps, your next step is to transfer the money for your investment:
Watch this video walkthrough if you need help depositing funds into your new brokerage account.
Once you have decided on the best place to buy Ikena Oncology stock, it's absolutely critical to research their stock before you buy, so you can understand the risk as well as the upside.
WallStreetZen was created to help everyday investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on IKNA's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge IKNA's intrinsic value.
Using relative valuations ratios:
You can access more valuation analysis on IKNA's stock here.
You can dig deeper into what analysts are forecasting on the Ikena Oncology stock forecast page.
Last year, IKNA revenue was $0.00. During the past four year, IKNA's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 43.24%.
Find out more about IKNA's earnings and revenue performance here.
In the last year, executives and large shareholders at IKNA have not bought or sold any shares.
Get more info about who owns IKNA shares here.
No, Ikena Oncology doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two main options:
Click the Open Trade button and your broker will execute your order.
If you need additional info about buying stocks on eToro, watch the how to video below:
Now that you own some IKNA shares, you'll want to stay up-to-date on your new company.
Make a watchlist to keep track of your IKNA stock.
To reiterate, here are the 6 steps you need to take to buy Ikena Oncology stock right now:
If you need a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to track your new investment in Ikena Oncology, add IKNA to your watchlist below.